Health
Sidra Medicine treats 10th patient with Duchenne Muscular Dystrophy
Sidra Medicine in Qatar provides specialised gene‑therapy‑based treatment to a child from Egypt diagnosed with Duchenne Muscular Dystrophy.
Sidra Medicine, a member of Qatar Foundation, has treated its 10th patient with Duchenne Muscular Dystrophy (DMD), a severe genetic muscle‑wasting disorder. The treatment is delivered through Sidra Medicine’s gene‑therapy centre, which brings together specialised expertise and multidisciplinary care for children with complex genetic conditions. The patient, a child from Egypt, received protocol‑driven care under this advanced therapeutic programme, highlighting Qatar’s role in providing specialised paediatric genetic therapies in the region.
- Status
- active
- Location
- Doha, Qatar
- Date added
- 2026-04-01 10:08 UTC
- Added by
- dinaasiaapdrmis
- Last updated
- 2026-04-01 10:08 UTC
- Connected threats
-
- Not Available